Welsis (WLSS) Revenue (2022 - 2023)

Welsis (WLSS) recorded quarterly Revenue of $2000.0 in Q4 2023, down 91.3% quarter-over-quarter from $23000.0 in Q3 2023, and down 42.86% on a YoY basis from $3500.0 in Q4 2022.

Welsis (WLSS) Revenue (2022 - 2023) Analysis & Trends

Welsis' Revenue history runs 2 years deep, the most recent figure standing at $2000.0 for Q4 2023.

  • In Q4 2023, Revenue fell 42.86% year-over-year to $2000.0; the TTM figure through Sep 2024 stood at $2000.0 (down 93.53% YoY), while the FY2024 annual figure was $2000.0, down 93.53% from the prior year.
  • Revenue was $2000.0 for Q4 2023 at Welsis, down from $23000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $23000.0 in Q3 2023 to a low of $2000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 882.95 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 3.61 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 354.64 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 182.31 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 150.84 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 145.37 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 313.87 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 603.85 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 309.88 Mn
10 Welsis - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 2,000.00
Sep 30, 2023 23,000.00
Jun 30, 2023 4,400.00
Dec 31, 2022 3,500.00